Kolon TissueGene, Inc. (KOSDAQ: 950160)

Market Cap	1.07T
Revenue	n/a
Net Income	n/a
Shares Out	79.47M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	203,117
Open	13,280
Previous Close	13,280
Day's Range	13,190 - 13,690
52-Week Range	7,710 - 21,800
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Kolon TissueGene

Kolon TissueGene, Inc. develops cell therapies to target various orthopedic diseases and degenerative disorders. The company is developing cell therapies for osteoarthritis and musculoskeletal system disorders, as well as vet medicine. Kolon TissueGene, Inc. was formerly known as TissueGene, Inc. and changed its name to Kolon TissueGene, Inc. in March 2018. The company was founded in 1999 and is headquartered in Rockville, Maryland.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1999
• Employees: 29
• Stock Exchange: KOSDAQ
• Ticker Symbol: 950160